Happy New Year from Sebela Pharmaceuticals. May you be happy the whole year through. #CountYourBlessings #HappyNewYear #2025IsTheYear
Sebela Pharmaceuticals Inc.
制药业
Roswell，Georgia 5,894 位关注者
Our Mission is to improve patients’ lives with innovative pharmaceuticals.
关于我们
Sebela Pharmaceuticals is a U.S. pharmaceutical company with a market-leading position in Gastroenterology and a focus on innovation in Women’s Health. Our Vision is to build the leading Gastroenterology company in the U.S., with a complementary focus on innovation in Women’s Health, premised on our expertise in pharmaceutical development and commercialization. We value dedication, energy, and enthusiasm, and we focus on innovation and results while striving to achieve our corporate mission and vision. Sebela Pharmaceuticals is committed to cultivating an inclusive environment where all employees are treated with respect. We accomplish this by fostering a culture of diversity, equity and inclusion, which is essential to innovation and continuous improvement. Sebela operates from three locations with offices in Roswell, Georgia, Braintree, MA and headquarters in Dublin, Ireland.
- 网站
-
https://www.sebelapharma.com
Sebela Pharmaceuticals Inc.的外部链接
- 所属行业
- 制药业
- 规模
- 201-500 人
- 总部
- Roswell，Georgia
- 类型
- 私人持股
- 创立
- 2013
- 领域
- Gastroenterology、Women's Health和Dermatology
地点
Sebela Pharmaceuticals Inc.员工
动态
-
To you, from all of us at Sebela Pharmaceuticals, have a very Merry Christmas and a Happy New Year. #MerryChristmas #HappyHoliday
-
-
In 2016, the Centers for Medicare & Medicaid Services clarified that bowel preps for colonoscopies should be provided without patient cost sharing. Yet, nearly 50% of patients are encouraged to use over-the-counter regimens not approved by the FDA as a bowel prep. This shifts the cost of the prep directly to the patient. #SayNoToPrepHesitancy #CostofCRC #ColorectalCancer #PrioritizeCRC
-
-
The Affordable Care Act requires that colon cancer screenings be accessible to patients with no cost sharing under the preventative care provision. The Centers for Medicare & Medicaid Services have also shared via FAQ (2016) that the colonoscopy prep should be provided at no cost-sharing. Yet, 83% of patients still pay some amount out-of-pocket for their preparation. #CostofCRC #SayNoToPrepHesitancy #ColorectalCancer #PrioritizeCRC
-
-
Payer restrictions often limit access to modern, low-volume bowel preparations. The result is greater use of over-the-counter (OTC), laxative-based preparations, which the FDA does not approve. This practice shifts the cost from the payer to the patient. #CostofCRC #SayNoToPrepHesitancy #ColorectalCancer #PrioritizeCRC
-
-
Today is the day to give thanks for all that is important to you, and we at Sebela Pharmaceuticals are grateful for you. #Thankful #GiveThanks
-
-
Section 2713 of the Affordable Care Act (ACA) mandates that all insurers MUST cover a patient’s cost for colorectal cancer (CRC) and other cancer screenings. As part of the screening procedure, CMS has stated that the colon prep be provided without patient cost sharing, yet 83% of patients pay more than $0 for their prep. #PrepareScreenSurvive #CostofCRC #SayNoToPrepHesitancy #ColorectalCancer
-
-
About half of all colonoscopy patients are prescribed a non–FDA-approved over-the-counter prep. #PrepareScreenSurvive #CostofCRC #SayNoToPrepHesitancy #ColorectalCancer
-